Others believe that this move was an attempt to avoid being tried in Pennsylvania, where a recent Supreme Court decision (Lance vs Wyeth) upheld that a drug manufacturer can be held responsible for any injuries resulting from distributing a product that was too dangerous to be in the market in the first place.